Balance Sheet Changchun BCHT Biotechnology Co.

Stocks

688276

CNE100005XY6

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 2026-06-12			5-day change	1st Jan Change
14.54 ^CNY	+0.35%		-2.55%	-22.91%

04-21	Changchun BCHT Biotechnology Co. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-26	Changchun BCHT Biotechnology Co. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

0f.YaeZpZHRkI45rK1jZBMOehetqZsA5aAjwseYJw6gnzY.VsTJzaHmz-FNz_UFJ3lFGGec4Kx5rfBG8a6oTFeSqX4YzqD397fyo0ve9A

Published financial data: CHANGCHUN BCHT BIOTECHNOLOGY CO.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.2B	1.07B	1.82B	1.23B	605M
Other Revenues, Total	746K	46.54K	136K	-	30.96K
Total Revenues	1.2B	1.07B	1.82B	1.23B	605M
Cost of Goods Sold, Total	229M	182M	210M	206M	213M
Gross Profit	973M	890M	1.61B	1.02B	392M
Selling General & Admin Expenses, Total	556M	553M	801M	583M	498M
Provision for Bad Debts	10.77M	33.63M	60.33M	23.48M	21.17M
R&D Expenses	157M	134M	198M	156M	177M
Other Operating Expenses	10.58M	9.7M	13.04M	9.83M	2.97M
Other Operating Expenses, Total	734M	730M	1.07B	772M	699M
Operating Income	239M	160M	542M	251M	-307M
Interest Expense, Total	-329K	-	-705K	-1.52M	-3.9M
Interest And Investment Income	11.78M	18.4M	12.44M	4.6M	3.07M
Net Interest Expenses	11.45M	18.4M	11.74M	3.08M	-832K
Income (Loss) On Equity Invest.	-	308K	690K	-440K	-34.41M
Currency Exchange Gains (Loss)	-136K	1.86M	669K	868K	123K
Other Non Operating Income (Expenses)	-164K	-152K	-208K	-248K	-261K
EBT, Excl. Unusual Items	251M	180M	555M	254M	-342M
Gain (Loss) On Sale Of Investments	-1.02M	-	-	-	-
Gain (Loss) On Sale Of Assets	76	-726K	-902K	-2.55M	-357K
Asset Writedown	-2.19M	-	-	-778K	-9.07M
Insurance Settlements	-	-	6.9M	698K	-
Other Unusual Items	14.2M	18.07M	2.91M	4.41M	19.99M
EBT, Incl. Unusual Items	262M	198M	564M	256M	-332M
Income Tax Expense	18.01M	16.16M	62.75M	23.68M	-69.32M
Earnings From Continuing Operations	244M	182M	501M	232M	-263M
Net Income to Company	244M	182M	501M	232M	-263M
Net Income - (IS)	244M	182M	501M	232M	-263M
Net Income to Common Incl Extra Items	244M	182M	501M	232M	-263M
Net Income to Common Excl. Extra Items	244M	182M	501M	232M	-263M
Per Share Items
Net EPS - Basic	0.62	0.44	1.21	0.56	-0.64
Basic EPS - Continuing Operations	0.62	0.44	1.21	0.56	-0.64
Basic Weighted Average Shares Outstanding	393M	413M	414M	414M	410M
Net EPS - Diluted	0.62	0.44	1.21	0.56	-0.64
Diluted EPS - Continuing Operations	0.62	0.44	1.21	0.56	-0.64
Diluted Weighted Average Shares Outstanding	393M	413M	414M	414M	410M
Normalized Basic EPS	0.4	0.27	0.84	0.38	-0.52
Normalized Diluted EPS	0.4	0.27	0.84	0.38	-0.52
Dividend Per Share	0.1	0.15	0.15	0.17	-
Payout Ratio	-	22.74	12.5	26.73	-26.62
Supplemental Items
EBITDA	308M	231M	634M	355M	-176M
EBITA	265M	186M	581M	294M	-258M
EBIT	239M	160M	542M	251M	-307M
EBITDAR	-	232M	635M	357M	-174M
Total Revenues (As Reported)	1.2B	1.07B	1.82B	1.23B	605M
Effective Tax Rate - (Ratio)	6.89	8.17	11.13	9.26	20.89
Total Current Taxes	27.97M	36.4M	98.15M	27.65M	-3.57M
Total Deferred Taxes	-9.95M	-20.24M	-35.4M	-3.97M	-65.75M
Normalized Net Income	157M	113M	347M	159M	-214M
Interest Capitalized	-	-	-	809K	1.22M
Supplemental Operating Expense Items
Advertising Expense	412M	371M	569M	436M	331M
Selling and Marketing Expenses	453M	412M	647M	478M	392M
General and Administrative Expenses	103M	141M	154M	105M	106M
Research And Development Expense From Footnotes	157M	134M	209M	188M	215M
Net Rental Expense, Total	-	1.47M	1.47M	2.11M	2.45M
Imputed Operating Lease Interest Expense	-	-	-	637K	545K
Imputed Operating Lease Depreciation	-	-	-	1.47M	1.9M
Maintenance & Repair Expenses, Total	5.55M	3.36M	5.58M	5.06M	2.03M
Stock-Based Comp., COGS (Total)	-	-	-	-292K	-
Stock-Based Comp., R&D Exp. (Total)	-	1.71M	8.98M	-79.9K	-6.28M
Stock-Based Comp., S&M Exp. (Total)	-	749K	4.69M	-277K	-2.58M
Stock-Based Comp., G&A Exp. (Total)	-	2.87M	18.58M	-1.56M	-9.19M
Stock-Based Comp., Other (Total)	-	-	-	-446K	-5.43M
Total Stock-Based Compensation	-	5.32M	32.25M	-2.66M	-23.48M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.16B	867M	442M	345M	201M
Total Cash And Short Term Investments	1.16B	867M	442M	345M	201M
Accounts Receivable, Total	764M	968M	1.57B	1.41B	937M
Other Receivables	-	-	-	-	-
Total Receivables	764M	968M	1.57B	1.41B	937M
Inventory	241M	192M	199M	171M	227M
Prepaid Expenses	-	100K	924K	1.11M	1.08M
Other Current Assets, Total	29.15M	30.81M	35.26M	41.21M	57.23M
Total Current Assets	2.19B	2.06B	2.24B	1.96B	1.42B
Gross Property Plant And Equipment	1.68B	1.92B	2.42B	2.88B	3.1B
Accumulated Depreciation	-241M	-280M	-330M	-402M	-491M
Net Property Plant And Equipment	1.44B	1.64B	2.09B	2.48B	2.61B
Long-term Investments	69.12M	61.28M	208M	211M	364M
Other Intangibles, Total	224M	204M	347M	331M	321M
Deferred Tax Assets Long-Term	31.93M	54.2M	90.97M	96.28M	164M
Deferred Charges Long-Term	159M	211M	29.26M	74.68M	154M
Other Long-Term Assets, Total	61.95M	53.06M	41.06M	49.56M	30.12M
Total Assets	4.17B	4.28B	5.05B	5.2B	5.07B
Liabilities
Accounts Payable, Total	63.91M	24.8M	17.49M	13.81M	19.6M
Accrued Expenses, Total	423M	341M	553M	533M	521M
Short-term Borrowings	-	-	20.47M	42.9M	181M
Current Portion of Long-Term Debt	-	-	-	-	20.47M
Current Income Taxes Payable	-	5.07M	48.89M	-	-
Unearned Revenue Current, Total	10.21M	8.65M	283K	2.2M	11.92M
Other Current Liabilities	252M	337M	375M	325M	351M
Total Current Liabilities	749M	717M	1.01B	917M	1.1B
Long-Term Debt	-	-	-	59.93M	63.58M
Unearned Revenue Non Current	8.09M	5.92M	9.86M	9M	48.26M
Deferred Tax Liability Non Current	-	1.11M	981K	881K	781K
Other Non Current Liabilities	253K	307K	173K	243K	2.28K
Total Liabilities	757M	724M	1.03B	987M	1.22B
Common Stock, Total	413M	413M	413M	414M	414M
Additional Paid In Capital	1.77B	1.78B	1.82B	1.84B	1.82B
Retained Earnings	1.24B	1.38B	1.82B	1.99B	1.66B
Comprehensive Income and Other	-5.75M	-10.96M	-31.86M	-25.27M	-36.83M
Total Common Equity	3.42B	3.56B	4.02B	4.22B	3.85B
Total Equity	3.42B	3.56B	4.02B	4.22B	3.85B
Total Liabilities And Equity	4.17B	4.28B	5.05B	5.2B	5.07B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	413M	413M	413M	414M	414M
ECS Total Common Shares Outstanding	413M	413M	413M	414M	414M
Book Value / Share	8.28	8.62	9.74	10.2	9.31
Tangible Book Value	3.19B	3.36B	3.67B	3.89B	3.53B
Tangible Book Value Per Share	7.74	8.13	8.9	9.4	8.53
Total Debt	0	0	20.47M	103M	265M
Net Debt	-1.16B	-867M	-422M	-242M	64M
Debt Equivalent Oper. Leases	-	11.73M	11.73M	16.87M	19.59M
Equity Method Investments, Total	35.88M	34.17M	34.86M	33.48M	350M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	148M	105M	81.68M	54.71M	55.43M
Inventories - Work In Process, Total	27.08M	43.44M	51.76M	33.82M	83.98M
Inventories - Finished Goods, Total	138M	85.22M	92.2M	116M	130M
Buildings, Total	308M	375M	488M	548M	560M
Machinery, Total	452M	510M	826M	946M	942M
Full Time Employees	1.23K	1.25K	1.24K	1.27K	1.25K
Accumulated Allowance for Doubtful Accounts (Supple)	19.89M	28.75M	60.36M	66.17M	73.76M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	244M	182M	501M	232M	-263M
Depreciation & Amortization - CF	43.05M	44.93M	53M	60.67M	82.01M
Amortization of Goodwill and Intangible Assets - (CF)	25.29M	26.01M	38.99M	43.51M	48.95M
Depreciation & Amortization, Total	68.34M	70.94M	91.99M	104M	131M
Amortization of Deferred Charges, Total - (CF)	987K	5.68M	7.01M	9.15M	19.13M
(Gain) Loss From Sale Of Asset	-76	726K	902K	2.55M	357K
(Gain) Loss on Sale of Investments - (CF)	1.02M	-308K	-690K	440K	34.41M
Asset Writedown & Restructuring Costs	2.19M	-	-	778K	9.07M
Provision for Credit Losses	-	21.09M	28.65M	-	-
Provision and Write-off of Bad Debts	5.35M	12.54M	31.67M	6.13M	8.69M
Other Operating Activities, Total	88.01M	41.34M	27.31M	40.06M	66.52M
Change In Accounts Receivable	-40.04M	-171M	-691M	122M	466M
Change In Inventories	-166M	7.89M	-33.53M	20.66M	-64.51M
Change In Accounts Payable	-51.67M	-109M	328M	-127M	-111M
Change In Deferred Taxes	-10.97M	-21.16M	-35.4M	-3.97M	-65.75M
Cash from Operations	140M	39.82M	255M	407M	231M
Capital Expenditure	-633M	-291M	-471M	-542M	-406M
Sale of Property, Plant, and Equipment	15K	-	36K	-	64.4K
Investment in Marketable and Equity Securities, Total	-62.64M	-	-168M	-	-50M
Other Investing Activities, Total	-	2.02M	-	941K	-
Cash from Investing	-696M	-289M	-639M	-541M	-456M
Short Term Debt Issued, Total	67.5M	-	197M	-	-
Long-Term Debt Issued, Total	-	-	-	337M	335M
Total Debt Issued	67.5M	-	197M	337M	335M
Short Term Debt Repaid, Total	-67.5M	-	-176M	-	-
Long-Term Debt Repaid, Total	-	-	-	-254M	-172M
Total Debt Repaid	-67.5M	-	-176M	-254M	-172M
Issuance of Common Stock	1.41B	-	-	19M	-
Common Dividends Paid	-	-41.28M	-62.61M	-62.05M	-69.91M
Common & Preferred Stock Dividends Paid	-	-41.28M	-62.61M	-62.05M	-69.91M
Other Financing Activities, Total	-10.4M	-	-	-2.35M	-5.12M
Cash from Financing	1.4B	-41.28M	-42.14M	36.97M	87.38M
Foreign Exchange Rate Adjustments	-97.36K	1.66M	503K	705K	-159K
Net Change in Cash	847M	-289M	-425M	-97.31M	-138M
Supplemental Items
Cash Interest Paid	329K	-	705K	2.35M	5.12M
Cash Income Tax Paid (Refund)	103M	77.93M	121M	140M	37.09M
Levered Free Cash Flow	-468M	-298M	-334M	-214M	-47.14M
Unlevered Free Cash Flow	-468M	-298M	-334M	-213M	-44.7M
Change In Net Working Capital	53.78M	189M	333M	-62.44M	-427M
Net Debt Issued / Repaid	0	-	20.47M	82.36M	162M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.51	2.36	7.26	3.06	-3.74
Return on Total Capital	5.76	2.87	8.91	3.75	-4.55
Return On Equity %	9.37	5.2	13.22	5.63	-6.51
Return on Common Equity	9.37	5.2	13.22	5.63	-6.51
Margin Analysis
Gross Profit Margin %	80.99	83.02	88.47	83.23	64.82
SG&A Margin	46.25	51.59	43.89	47.42	82.31
EBITDA Margin %	25.6	21.55	34.74	28.88	-29.11
EBITA Margin %	22.02	17.35	31.84	23.94	-42.66
EBIT Margin %	19.92	14.93	29.7	20.4	-50.75
Income From Continuing Operations Margin %	20.26	16.94	27.46	18.88	-43.4
Net Income Margin %	20.26	16.94	27.46	18.88	-43.4
Net Avail. For Common Margin %	20.26	16.94	27.46	18.88	-43.4
Normalized Net Income Margin	13.03	10.52	19	12.92	-35.37
Levered Free Cash Flow Margin	-38.93	-27.8	-18.33	-17.37	-7.79
Unlevered Free Cash Flow Margin	-38.91	-27.8	-18.3	-17.3	-7.39
Asset Turnover
Asset Turnover	0.36	0.25	0.39	0.24	0.12
Fixed Assets Turnover	1.08	0.7	0.98	0.54	0.24
Receivables Turnover (Average Receivables)	1.6	1.24	1.44	0.83	0.52
Inventory Turnover (Average Inventory)	1.18	0.84	1.08	1.11	1.07
Short Term Liquidity
Current Ratio	2.93	2.87	2.21	2.14	1.29
Quick Ratio	2.56	2.56	1.98	1.91	1.03
Operating Cash Flow to Current Liabilities	0.19	0.06	0.25	0.44	0.21
Days Sales Outstanding (Average Receivables)	227.44	295.08	253.63	442.79	706.87
Days Outstanding Inventory (Average Inventory)	309.43	434.81	339.34	328.4	340.61
Average Days Payable Outstanding	55.2	122	35.52	32.21	22.7
Cash Conversion Cycle (Average Days)	481.67	607.89	557.44	738.98	1.02K
Long Term Solvency
Total Debt/Equity	-	-	0.51	2.44	6.89
Total Debt / Total Capital	-	-	0.51	2.38	6.44
LT Debt/Equity	-	-	-	1.42	1.65
Long-Term Debt / Total Capital	-	-	-	1.39	1.54
Total Liabilities / Total Assets	18.13	16.9	20.33	18.97	24.02
EBIT / Interest Expense	728.25	-	768.77	165.1	-78.66
EBITDA / Interest Expense	936.1	-	899.25	233.69	-45.12
(EBITDA - Capex) / Interest Expense	-988.88	-	231.61	-123.46	-149.24
Total Debt / EBITDA	-	-	0.03	0.29	-1.51
Net Debt / EBITDA	-3.75	-3.75	-0.67	-0.68	-0.36
Total Debt / (EBITDA - Capex)	-	-	0.13	-0.55	-0.46
Net Debt / (EBITDA - Capex)	3.55	14.48	-2.58	1.29	-0.11
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-16.6	-10.86	70.3	-32.64	-50.77
Gross Profit, 1 Yr. Growth %	-23.05	-8.62	81.48	-36.63	-61.66
EBITDA, 1 Yr. Growth %	-42.04	-24.98	174.59	-44.01	-149.62
EBITA, 1 Yr. Growth %	-45.99	-29.76	212.43	-49.35	-187.73
EBIT, 1 Yr. Growth %	-49.29	-33.2	238.87	-53.73	-222.47
Earnings From Cont. Operations, 1 Yr. Growth %	-41.77	-25.46	175.98	-53.67	-213.14
Net Income, 1 Yr. Growth %	-41.77	-25.46	175.98	-53.67	-213.14
Normalized Net Income, 1 Yr. Growth %	-47.26	-27.73	207.66	-54.22	-234.83
Diluted EPS Before Extra, 1 Yr. Growth %	-45.61	-29.03	175	-53.72	-214.29
Accounts Receivable, 1 Yr. Growth %	4.2	26.77	61.84	-10.24	-33.4
Inventory, 1 Yr. Growth %	65.08	-20.4	3.6	-14.19	32.66
Net Property, Plant and Equip., 1 Yr. Growth %	83.71	14.13	27	18.82	5.45
Total Assets, 1 Yr. Growth %	69.18	2.61	17.8	3.14	-2.62
Tangible Book Value, 1 Yr. Growth %	108.56	5.06	9.46	5.83	-9.18
Common Equity, 1 Yr. Growth %	92	4.15	12.95	4.91	-8.7
Cash From Operations, 1 Yr. Growth %	-32.92	-71.62	540.93	59.28	-43.12
Capital Expenditures, 1 Yr. Growth %	88.5	-54.06	61.89	15.25	-25.06
Levered Free Cash Flow, 1 Yr. Growth %	163.03	-36.34	12.28	-36.14	-77.85
Unlevered Free Cash Flow, 1 Yr. Growth %	166.71	-36.31	12.13	-36.34	-78.9
Dividend Per Share, 1 Yr. Growth %	-	50	0	12.67	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	11	-13.78	23.21	7.1	-42.42
Gross Profit, 2 Yr. CAGR %	5.6	-16.15	28.78	7.24	-50.71
EBITDA, 2 Yr. CAGR %	-2.63	-34.06	43.52	23.99	-47.29
EBITA, 2 Yr. CAGR %	-3.76	-38.41	48.14	25.8	-33.34
EBIT, 2 Yr. CAGR %	-7.83	-41.8	50.45	25.21	-24.73
Earnings From Cont. Operations, 2 Yr. CAGR %	4.97	-34.12	43.43	13.07	-27.6
Net Income, 2 Yr. CAGR %	4.97	-34.12	43.43	13.07	-27.6
Normalized Net Income, 2 Yr. CAGR %	-4.38	-38.39	49.11	18.68	-21.44
Diluted EPS Before Extra, 2 Yr. CAGR %	0.82	-37.87	39.7	12.82	-27.27
Accounts Receivable, 2 Yr. CAGR %	51.98	14.93	43.23	20.52	-22.69
Inventory, 2 Yr. CAGR %	67.06	14.63	-9.19	-5.72	6.69
Net Property, Plant and Equip., 2 Yr. CAGR %	52.6	44.8	20.4	22.84	11.94
Total Assets, 2 Yr. CAGR %	62.38	31.76	9.94	10.23	0.22
Tangible Book Value, 2 Yr. CAGR %	84.5	48.03	7.24	7.63	-1.96
Common Equity, 2 Yr. CAGR %	83.67	41.41	8.46	8.85	-2.13
Cash From Operations, 2 Yr. CAGR %	-22.37	-56.37	34.87	219.51	-4.82
Capital Expenditures, 2 Yr. CAGR %	122.02	-6.95	-13.76	36.59	-7.07
Levered Free Cash Flow, 2 Yr. CAGR %	137.38	29.4	-15.46	-15.33	-62.46
Unlevered Free Cash Flow, 2 Yr. CAGR %	130.25	30.33	-15.49	-15.52	-63.42
Dividend Per Share, 2 Yr. CAGR %	-	-	22.47	6.14	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.66	3.17	8.18	0.74	-17.34
Gross Profit, 3 Yr. CAGR %	2.65	0.63	8.47	1.67	-23.89
EBITDA, 3 Yr. CAGR %	18.02	-10.74	6.08	4.87	-8.63
EBITA, 3 Yr. CAGR %	19.08	-13.35	5.83	3.59	11.55
EBIT, 3 Yr. CAGR %	15.5	-17.21	4.7	1.55	24.29
Earnings From Cont. Operations, 3 Yr. CAGR %	23.9	-6.35	6.2	-1.59	13.09
Net Income, 3 Yr. CAGR %	23.9	-6.35	6.2	-1.59	13.09
Normalized Net Income, 3 Yr. CAGR %	19.84	-13.02	5.31	0.59	23.83
Diluted EPS Before Extra, 3 Yr. CAGR %	19.87	-10.32	2.01	-3.34	13.3
Accounts Receivable, 3 Yr. CAGR %	40.43	43.06	28.82	22.57	-1.1
Inventory, 3 Yr. CAGR %	34.62	30.48	10.83	-10.89	5.65
Net Property, Plant and Equip., 3 Yr. CAGR %	35.04	38.52	38.61	19.87	16.75
Total Assets, 3 Yr. CAGR %	43.58	39.34	26.93	7.63	5.77
Tangible Book Value, 3 Yr. CAGR %	61.89	52.92	33.86	6.77	1.71
Common Equity, 3 Yr. CAGR %	62.29	52.03	31.21	7.26	2.66
Cash From Operations, 3 Yr. CAGR %	-19.58	-44.49	6.86	42.56	79.74
Capital Expenditures, 3 Yr. CAGR %	51.74	31.32	11.92	-5.01	11.82
Levered Free Cash Flow, 3 Yr. CAGR %	-	53.08	23.42	-23.01	-45.91
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	50.02	23.96	-23.11	-46.86
Dividend Per Share, 3 Yr. CAGR %	-	-	-	19.11	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	12.36	4.73	-15.94
Gross Profit, 5 Yr. CAGR %	-	-	12.39	3.22	-20.88
EBITDA, 5 Yr. CAGR %	-	-	27.63	1.8	-19.81
EBITA, 5 Yr. CAGR %	-	-	29.95	0.59	-12.04
EBIT, 5 Yr. CAGR %	-	-	28.38	-2.31	-8.25
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	31.37	0.98	-8.89
Net Income, 5 Yr. CAGR %	-	-	31.37	0.98	-8.89
Normalized Net Income, 5 Yr. CAGR %	-	-	30.68	-1.51	-6.34
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	27.44	-1.7	-10.9
Accounts Receivable, 5 Yr. CAGR %	-	-	41.55	33.58	5.02
Inventory, 5 Yr. CAGR %	-	-	15.01	14.58	9.16
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	28.98	32.02	27.25
Total Assets, 5 Yr. CAGR %	-	-	29.04	26.87	15.48
Tangible Book Value, 5 Yr. CAGR %	-	-	37.3	32.88	18.18
Common Equity, 5 Yr. CAGR %	-	-	38.13	33.01	16.69
Cash From Operations, 5 Yr. CAGR %	-	-	-1.11	11.79	2.02
Capital Expenditures, 5 Yr. CAGR %	-	-	21.04	33.4	3.9
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	20.79	-23.33
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	19.23	-23.92